|
For Release May 19, 2005
NIDA to Host "Smart Practice, Practical Science: Blending Treatment and Research", June 6-7, 2005
| WHAT: | A 2-day conference that will bring together clinicians and researchers to examine cutting-edge scientific findings about drug abuse and addiction and their application to clinical practice. |
| WHY: | As in other fields of medicine, a gap exists in the drug abuse treatment field between clinical practice and scientific research. By bringing together leading drug abuse treatment clinicians and researchers, this conference will provide an opportunity to further bridge that gap. |
| HOSTS: | NIDA and the Florida Node of the NIDA Clinical Trials Network (CTN), located at the University of Miami, are sponsoring the conference |
| WHEN: | Monday and Tuesday, June 6-7, 2005 |
| WHERE: | The Sheraton Bal Harbour Hotel, 9701 Collins Avenue, Bal Harbour, Florida |
| WHO SHOULD ATTEND: | Drug treatment counselors, social workers, healthcare providers, criminal justice staff, marriage and family counselors, public health workers, physicians, researchers interested in drug abuse and addiction issues, and the media are encouraged to attend.
|
| INFO: |
BLENDING CONFERENCE OVERVIEW
|
Nora D. Volkow, M.D., Director, National Institute on Drug Abuse (NIDA), will present the opening plenary session, "Progress in Translating Drug Abuse Research into Clinical Practice," in the Grand Ballroom at 9:30 a.m. on Monday, June 6, 2005.
Below is a partial list of topics by NIDA-supported investigators.
| Monday, June 6 | (Concurrent Panel Sessions) |
| 11:15 a.m. - 1:00 p.m. | Evidence-Based Treatment for Co-Occurring Anxiety and Mood Disorders
Gender-Specific Treatment for Women
Newest Findings on the Effectiveness ofBuprenorphine Detoxification, Motivational Enhancement Therapy and Motivational Incentives
Nicotine Treatment in Substance Abuse Treatment Settings |
| 1:00 p.m. - 2:30 p.m. | Treatment Improvement Through Applied Research in Community Based Service Settings |
| | (Concurrent Workshops) |
| 2:30 p.m. - 5:30 p.m. | Motivational Incentives
Brief Strategic Family Therapy in the Treatment of Drug Abusing Adolescents
An Introduction to Motivational Interviewing |
| Tuesday, June 7 | (Concurrent Panel Sessions) |
| 11:15 a.m. - 1:00 p.m. | Research on Successful Dissemination
Challenges of Clinical Supervision of Empirically Supported Treatments
Emerging Drug Problems in Florida: Methamphetamine and Prescription Drugs
Drugs, the Brain, and Behavior
Assessment and Treatment of ADHD with Substance Abuse Treatment in Drug Abusing Adolescents
|
| | (Workshop) |
| 2:30 p.m. - 5:30 p.m. | HIV Interventions for Community Treatment Programs (CTP) |
Other highlights of the meeting include:
- Re-Considering Addiction Treatment: Quality, Accountability, and Outcomes in a Chronic Care Perspective, Tuesday, June 7, 1:00 p.m. - 2:30 p.m. by luncheon speaker, A. Thomas McClellan, Ph.D., Director, Treatment Research Institute.
- A Conversation with Bill Miller, Tuesday, June 7, 2:30-5:30 p.m. Dr. Miller has spent 30 years developing, evaluating and disseminating innovative and evidence-based treatments for substance use disorders. Among the treatments he has studied are behavioral self-control training, cognitive-behavior therapy, the community reinforcement approach, covert sensitization, and motivational interviewing. This 3-hour unstructured session will include a brief overview of his work and open conversation.
- Updating Prevention of HIV Infection in Drug Users, Tuesday, June 7, 10-11 a.m. Dr. David Vlahov has been Principal Investigator of the ALIVE Study, which, for 19 years, has recruited and followed over 3,000 injection drug users in Baltimore for a variety of health outcomes. He will discuss how clinicians can incorporate the latest research about HIV prevention and treatment into their care of drug-using patients.
In addition, while the conference will be conducted in English, a number of sessions will also be translated live and made available in Spanish. More details about the conference are available on NIDA's website at www.drugabuse.gov.
DR. NORA D. VOLKOW, DIRECTOR, NIDA
Dr. Nora D. Volkow assumed the position of director of NIDA in May 2003. She is a recognized expert on the neurobiology of addiction. She is particularly known for her work investigating the mechanisms underlying the reinforcing, addictive, and toxic properties of drugs of abuse in the human brain. As a researcher, Dr. Volkow has been supported by grants from NIDA, NIAAA, and the Department of Energy. Her work also includes more than 275 peer-reviewed publications, three edited books and more than 50 book chapters and non-peer-reviewed manuscripts. A recipient of multiple awards, she was elected to membership in the Institute of Medicine, National Academy of Sciences, and was named "Innovator of the Year" in 2000 by U.S. News and World Report.
For more information or to arrange an interview with NIDA Director Dr. Nora D. Volkow, please contact the NIDA Press Office at 301-443-6245. Dr. Volkow is bilingual and media interviews can be conducted in either English or Spanish.
The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and further information on NIDA research can be found on the NIDA web site at http://www.drugabuse.gov.
|
|
For more information about any item in this Release:
- Contact:
301-443-6245
Contacto en Español:
301-594-6145
|
|
